The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Open accessAbstract
Inhibition of the Wnt antagonist sclerostin increases bone mass in patients with osteoporosis and in preclinical animal models. Here we show increased levels of the Wnt antagonist Dickkopf-1 (DKK-1) in animals treated with sclerostin antibody, suggesting a negative feedback mechanism that limits Wnt-driven bone formation. To test our hypothesis that co-inhibition of both factors further increases bone mass, we engineer a first-in-class bispecific antibody with single residue pair mutations in the Fab region to promote efficient and stable cognate light–heavy chain pairing. We demonstrate that dual inhibition of sclerostin and DKK-1 leads to synergistic bone formation in rodents and non-human primates. Furthermore, by targeting distinct facets of fracture healing, the bispecific antibody shows superior bone repair activity compared with monotherapies. This work supports the potential of this agent both for treatment and prevention of fractures and offers a promising therapeutic approach to reduce the burden of low bone mass disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 3×
“The qRT-PCR amplification program was: (1) activation at 50 C for 2min; (2) denaturation at 95 C for 10min; (3) amplification 40 cycles at 95 C for 15 s and at 60 C for 1min with fluorescence capture at each step (ABI PRISM 7900HT Sequence Detection Systems, Applied Biosystems, Foster City, CA).”
BackgroundMethodSelf-citationMechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.-H., Duncan, E. L., Ntzani, E. E., Oei, L., Albagha, O. M. E., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,174
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Self-citationvan Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Self-citationIdentification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
Dickkopf1 Is Required for Embryonic Head Induction and Limb Morphogenesis in the Mouse
Mukhopadhyay, M., Shtrom, S., Rodriguez-Esteban, C., Chen, L., Tsukui, T., Gomer, L., Dorward, D. W., Glinka, A., Grinberg, A., Huang, S.-P., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00041-7 · Cited by 635
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Li, J., Sarosi, I., Cattley, R. C., Pretorius, J., Asuncion, F., Grisanti, M., Morony, S., Adamu, S., Geng, Z., Qiu, W., et al. (2006) · Bone · doi:10.1016/j.bone.2006.03.017 · Cited by 441
Self-citationOminsky, M. S., Vlasseros, F., Jolette, J., Smith, S. Y., Stouch, B., Doellgast, G., Gong, J., Gao, Y., Cao, J., Graham, K., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.14 · Cited by 414
Self-citationAnti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y.-T., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 399
Chen, Y., Whetstone, H. C., Lin, A. C., Nadesan, P., Wei, Q., Poon, R., & Alman, B. A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040249 · Cited by 391
Chamorro, M. N., Schwartz, D. R., Vonica, A., Brivanlou, A. H., Cho, K. R., & Varmus, H. E. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600460 · Cited by 298
Recker, R. R., Benson, C. T., Matsumoto, T., Bolognese, M. A., Robins, D. A., Alam, J., Chiang, A. Y., Hu, L., Krege, J. H., Sowa, H., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2351 · Cited by 293
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
Gunasekaran, K., Pentony, M., Shen, M., Garrett, L., Forte, C., Woodward, A., Ng, S. B., Born, T., Retter, M., Manchulenko, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117382 · Cited by 280
Self-citationOminsky, M. S., Li, C., Li, X., Tan, H. L., Lee, E., Barrero, M., Asuncion, F. J., Dwyer, D., Han, C.-Y., Vlasseros, F., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.307 · Cited by 264
Self-citationAi, M., Holmen, S. L., Van Hul, W., Williams, B. O., & Warman, M. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4946-4955.2005 · Cited by 253
Bourhis, E., Tam, C., Franke, Y., Bazan, J. F., Ernst, J., Hwang, J., Costa, M., Cochran, A. G., & Hannoush, R. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092130 · Cited by 230
LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semenov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
Cheng, Z., Biechele, T., Wei, Z., Morrone, S., Moon, R. T., Wang, L., & Xu, W. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2139 · Cited by 202
Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6
Ahn, V. E., Chu, M. L.-H., Choi, H.-J., Tran, D., Abo, A., & Weis, W. I. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.003 · Cited by 201
Ozaki, A., Tsunoda, M., Kinoshita, S., & Saura, R. (2000) · Journal of Orthopaedic Science · doi:10.1007/s007760050010 · Cited by 181
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wei, W., Zeve, D., Suh, J. M., Wang, X., Du, Y., Zerwekh, J. E., Dechow, P. C., Graff, J. M., & Wan, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05980-11 · Cited by 181
Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
Bourhis, E., Wang, W., Tam, C., Hwang, J., Zhang, Y., Spittler, D., Huang, O. W., Gong, Y., Estevez, A., Zilberleyb, I., et al. (2011) · Structure · doi:10.1016/j.str.2011.07.005 · Cited by 168
Ominsky, M. S., Niu, Q.-T., Li, C., Li, X., & Ke, H. Z. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2152 · Cited by 167
Self-citationIyer, S. P., Beck, J. T., Stewart, A. K., Shah, J. J., Kelly, K. R., ISAACS, R. E., Bilic, S., Sen, S., & Munshi, N. C. (2014) · British Journal of Haematology · doi:10.1111/bjh.13056 · Cited by 157
The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
Balemans, W., Piters, E., Cleiren, E., Ai, M., Wesenbeeck, L. V., Warman, M. L., & Hul, W. V. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9130-9 · Cited by 149
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
Li, X., Grisanti, M. S., Fan, W., Asuncion, F., Tan, H., Dwyer, D., Han, C.-Y. E., Yu, L., Lee, J. W., Lee, E., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.472 · Cited by 122
Self-citationStolina, M., Dwyer, D., Niu, Q., Villasenor, K. S., Kurimoto, P., Grisanti, M. S., Han, C.-Y. E., Liu, M., Li, X., Ominsky, M. S., et al. (2014) · Bone · doi:10.1016/j.bone.2014.07.031 · Cited by 100
Self-citationBajada, S., Marshall, M. J. E., Wright, K. T., Richardson, J. B., & Johnson, W. E. B. (2009) · Bone · doi:10.1016/j.bone.2009.06.015 · Cited by 98
Liu, Z., Leng, E. C., Gunasekaran, K., Pentony, M., Shen, M., Howard, M., Stoops, J. D., Manchulenko, K., Razinkov, V. I., Liu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620260 · Cited by 78
Self-citationAnastasilakis, A. D., Pοlyzos, S. A., Avramidis, A., Toulis, K. A., Παπαθεοδώρου, Α., & Terpos, E. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03728.x · Cited by 63
Serum Dickkopf 1 Levels in Sclerostin Deficiency
van Lierop, A. H., Moester, M. J. C., Hamdy, N. A. T., & Papapoulos, S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3278 · Cited by 51
Holmes, D. I. R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3581 · Cited by 43
Munshi, N. C., Abonour, R., Beck, J. T., et al. (2012) · Blood · doi:10.1182/blood.v120.21.331.331 · Cited by 41
Estes, B., Hsu, Y., Tam, L. T., Sheng, J., Stevens, J. L., & Haldankar, R. (2014) · Biotechnology Progress · doi:10.1002/btpr.2021 · Cited by 26
Self-citationEdenfield, W. J., Richards, D., Vukelja, S. J., Weiss, G. J., Sirard, C. A., Landau, S. B., & Ramanathan, R. K. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.8068 · Cited by 21
Cited by
Osteoporosis treatment: recent developments and ongoing challenges
Khosla, S., & Hofbauer, L. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30188-2 · Cited by 1,019
Ho-Shui-Ling, A., Bolander, J., Rustom, L. E., Johnson, A. W., Luyten, F. P., & Picart, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.017 · Cited by 961
Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease
Hu, L., Chen, W., Qian, A., & Li, Y.-P. (2024) · Bone Research · doi:10.1038/s41413-024-00342-8 · Cited by 359
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
Harmer, D., Falank, C., & Reagan, M. R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00788 · Cited by 307
Bispecific antibodies: design, therapy, perspectives
Sedykh, S., Prinz, V., Buneva, V., & Nevinsky, G. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s151282 · Cited by 292
Metadata
- Authors
- Florio, M., Gunasekaran, K., Stolina, M., Li, X., Liu, L., Tipton, B., Salimi-Moosavi, H., Asuncion, F. J., Li, C., Sun, B., Tan, H. L., Zhang, L., Han, C.-Y., Case, R., Duguay, A. N., Grisanti, M., Stevens, J., Pretorius, J. K., Pacheco, E., Jones, H., Chen, Q., Soriano, B. D., Wen, J., Heron, B., Jacobsen, F. W., Brisan, E., Richards, W. G., Ke, H. Z., & Ominsky, M. S.
- Venue
- Nature Communications
- Published
- 2016-05-27
- Volume
- 7
- Issue
- 1
- Pages
- 11505-11505
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2398309765
- Cited by
- 257
- References
- 43
- FWCI
- 34.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.